Breast Cancer Session

Dr. Aparna Dhar is a Mayo Clinic College of Medicine and University of Glasgow trained Medical Geneticist and Genetic Counsellor. She has over fifteen years of experience in academia, hereditary cancers and personalized genomic testing for guiding patient treatment and management. Over 10,000 families have benefitted from her Cancer Genetics clinic. Through the Genetics clinic a combination of genetic education and psychosocial support is implemented to empower patients to make informed decisions regarding their health. She has also gained experience as a Research fellow, Medical Geneticist & Genetic counsellor at Mayo Clinic, Broad Institute of MIT and Harvard and National Health Services (NHS) Scotland.

Dr. Archana has more than 20 years’ experience from UK, UAE & India She was Fully trained in the UK for 15 years. Ex-consultant Oncoplastic breast surgeon at Peterborough hospital (UK). Ex- Consultant Oncoplastic breast surgeon at Kokilaben Dhirubhai Ambani Hospital, Mumbai, India. Ex- Consultant Oncoplastic breast surgery at Narayana Health, Bangalore, India Dr Archana has been awarded the coveted Donald Mcneill Oncoplastic fellowship by the Association of Breast Surgeons UK. Fellow of Royal College Of Surgeons, UK Faculty at the Royal College of Surgeons of Edinburgh, UK Reviewer for the Indian Journal of Surgical Oncology & Dubai Medical Journal Dr. Archana has done extensive research at University College London on DNA replication markers as prognostic & predictive factors for breast cancer Published papers in multiple peer reviewed journals Invited as faculty in numerous international conferences.

Dr. Aydah is a Medical Oncologist and quality officer in Oncology at Tawam hospital, graduated from the MD Anderson Hematology and Medical Oncology fellowship in 2019. Main interest in breast cancer. Published several peer review research articles and multiple book chapters in breast cancer. She is American board certified in Internal Medicine, Hematology and Oncology.

Dr. Bhawna Sirohi is currently a consultant medical oncologist in GI & breast cancers and Director of Medical Oncology at BALCO Medical Centre,Nava Raipur, India. She is an honorary consultant with Queen Mary’s University, London. She was previously working at The Barts Health NHS Trust, London. She started her oncology training in India in 1994 at the Tata Memorial Centre, Mumbai and completed at Royal Marsden NHS Foundation Trust, UK. She has been working as consultant medical oncologist since 2008, in breast and GI cancers and acute oncology, both in India and UK. She has published more than 100 papers in national and international journals and lectured worldwide. She has edited three books on Cancer – Cancer- Questions Answered, Chemotherapy in GI cancers & Modern GI Oncology. She is the immediate past editor-in-chief of Indian Journal of Medical and Paediatric Oncology. She is currently the President of the Oncology section of the Royal Society of Medicine.

“Consultant Medical Oncology, DAHC since 2009 Ass prof Clinical Oncology Tanya University Egypt PhD clinical Oncology 2008 Master Clinical Oncology 2001 Member of ASCO, ESMO more than 20 Publications “

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; Lung cancer, GI malignancies, and breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dr. Dima Abdul Jabbar, MD, is a staff physician in the Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Dima served as Assistant Professor of Medical Oncology at the University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Florida, US. She has also worked as a Consultant Medical Oncologist at several reputable hospitals in Florida and the UAE. Dr. Dima has extensive experience with different types of chemotherapy and immunotherapy and has managed different kinds of cancers including breast cancer, melanomas, and colorectal neoplasms.

” Dr.Emad Anwar Dawoud, MD, PhD is a Consultant Clinical Oncology at Tawam Hospital (Affiliated with Johns Hopkins) Al Ain, UAE “

Giuseppe Curigliano, MD PhD, is Associate Professor of Medical Oncology at the University of Milano and the Head of the Division of Early Drug Development at the European Institute of Oncology, IRCCS, Italy. He is a clinician and researcher specialising in early drug development for patients with solid tumours with a special commitment to breast cancer. He has been a member of the Italian National Health Council since 2018 and, in 2019, he served as Chair of the Scientific Committee of The Lega Nazionale Lotta ai Tumori. He has served as a Member of the ESMO Breast Cancer Faculty since 2001 and he is currently the Faculty Coordinator. He has also served on the Scientific Committee for the St Gallen Conference since 2011, and was the Scientific Co-Chair in St Gallen 2017 and 2019. He has been an Editorial Board Member for Annals of Oncology since 2014, and serves as Co-Editor in Chief of The Breast, Co-Editor in Chief of Cancer Treatment Reviews, Associate Editor of the European Journal of Cancer, Editor of the Journal of Clinical Oncology. He also serves on the European School of Oncology (ESO) faculty committee.

Dr. Azim is a Professor of Clinical Oncology and immediate past chairman of the Department of Clinical Oncology, Faculty of Medicine, Cairo University. He is the president of the Cairo Oncology Center, one of the largest private Cancer centers in the Middle East region. Dr Azim chairs the scientific committee of the NCCN Middle East chapter and is a member of numerous societies, including the ASCO, ASH, ESMO, ASTRO and the European Blood and Marrow Transplantation Society.

Dr Javier Cortes is head of breast cancer and gynecological cancers at Hospital Universitario Ramón y Cajal in Madrid, Spain, as well as Clinical Investigator in the breast cancer research program at Vall d’Hebron Institute of Oncology in Barcelona, Spain. He is one of the European leaders in the field of HER2+ breast cancer, and has led fundamental trials that resulted in the approval of pertuzumab, eribulin and everolimus for metastatic breast cancer. He continues to actively participate in national and international clinical investigations to develop molecularly targeted therapies, such as CDK 4/6 inhibitors, and immunotherapies. Dr Cortés is on the Scientific Committee of ESMO and is an active member of ASCO and the Spanish Society of Medical Oncology.

She is the Head and Senior Consultant in Medical Oncology and Associate Director of Research at the National University Cancer Institute, Singapore, and Senior Principal Investigator at the Cancer Science Institute, Singapore. She is ex-Chairperson of the Chapter of Medical Oncologists, Academy of Medicine, Singapore, and has been a member of the Ministry of Health Specialist Accreditation Board for Medical Oncology since 2009. She has been Chair of the National Healthcare Group Domain-Specific Ethics Review Board B since 2008. She is also a member of the Singapore Ministry of Health Drug Advisory Committee for Oncology drugs. She specialises in breast cancer and directs the Cancer Genetics program at the National University Cancer Institute, Singapore. Her research focus is on breast cancer, pharmacogenetics and cancer genetics, and she has been the Principal Investigator of more than 40 industry-sponsored and investigator-initiated breast cancer clinical trials. She directs the Haematology-Oncology Research Group, a cancer clinical trials unit that conducts 100-120 phase I-III therapeutics clinical trials in solid tumours and haematological malignancies at the National University Cancer Institute.

Dr. Maroun El Khoury completed his basic medical training from Saint Joseph University School of Medicine Beirut, Lebanon in 1999. He is also a member of the American Society of Clinical Oncology, American Society of Hematology and American Academy of Pain Management. Dr. Maroun El Khoury’s specialty is Oncology and currently work as a Consultant Oncologist.

Chief Medical Director Dr. Mohsen Mokhtar is a professor of clinical oncology in Al-Kasr Al-Aini Medical School. Dr. Mohsen assisted in developing the syllabus and course structure at Al-Kasr Al-Aini, as well as, supervised several research programs and theses. Furthermore, Dr. Mokhtar has published more than 50 articles in several regional magazines in topics including: breast, lung, pediatric, colorectal, ovarian malignancies NHL and hematologic malignancies. Professionally, Dr. Mokhtar has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities

Dr Nita S. Nair is a Consultant, Breast Surgery at Apollo Cancer Centre, Mumbai. She has more than 15 years of experience in breast cancer and other breast conditions.

Dr. Nitesh Rohatgi is Senior Director Medical Oncology at Fortis Memorial Research Institute, Gurugram, he was previously working at the prestigious London Oncology Clinic (Leaders in Oncology care), Harley Street, London. He is a fellow of the Royal College of Physicians (U.K Edinburgh) as well as Royal Society of medicine. Besides being a key opinion leader in Oncology in India he has been a PI on clinical trials (presently for BIRAC -Oncology) and has much publication to his name. He was trained in medical oncology, palliative medicine and teenage young adult’s cancers in United Kingdom, completing his CCT in 2009.

Nouri Bennini has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France.

Dr. Omalkhair Abulkhair is currently a Consultant in the Division of Adult Medical, Department of Oncology in Ministry of National Guard Health Affairs – Saudi Arabia and Assistant Professor at the King Saud bin Abdulaziz University for Health Sciences. Being one of the most recognized oncologists in the Middle East, she was nominated to be part of the Women in High Places: Fight Against Cancer, an international organization of prominent women in their respective areas. She is the Course Director of major symposia in the department which is the “Middle East Best of San Antonio Breast Cancer Symposium” and “Cancer Prevention and Early Detection Symposium”. She was also selected as the Chairman for MENA-NCCN Guidelines Committee for Breast Cancer. This committee aims to unify the guidelines for breast cancer management in the region. Furthermore, Dr. Abulkhair has written numerous publications and abstracts which leads to receiving three awards for best abstract.

Dr. Rham Zaki is currently working in Zulekha Hospital, Sharjah as a Medical Oncologist. She was a Lecturer of medical oncology at the Medical Oncology Department at Zagazig University Faculty of Medicine from 2011 to October 2014. She was also an Assistant lecturer at the National Cancer Institute, Cairo University and Faculty of Medicine at Zagazig University from 2004 – 2011. She has worked in many local and private hospitals in Egypt such as: the Cairo National Cancer Institute in Zagazig University Hospital and Al Taesier, Aloubour Hospital.

 Shaheenah Dawood is a consultant medical oncologist and professor in clinical oncology in the United Arab Emirates. She currently leads the oncology clinical trials program at Mediclinic City Hospital Dubai. She also serves as president of the Excellence in Oncology Care summit that is held annually in Dubai and is co-president of the Asia-Pacific Breast Cancer Summit (APBCS) and Asia-Pacific Gastroenterology Cancer Summit (APGCS). She has also recently launched the International BRCA Forum and Young Women’s Forum.

Dr. Sonia Otsmane is an experienced Medical Oncology-Haematology Consultant since 2004. Graduated from the Central faculty of Medecine Algiers in 1994. MD degree. Oncology-hematology board : Pierre and Marie curie institute in 2004. ESMO member. Member of ASCO. Member of Emirates oncology and hematology society. Member of Oncology society and Algerian order of physicians. Main interest: breast cancer, sarcomas, GI and GU malignancies and lymphomas. Has an interest and implicated in several clinical research. Publications and research ongoing on Hematology malignancies (Multiple myeloma /Lymphoma), Solid tumors mainly Breast cancer Head and neck tumors and Immunotherapy.

Stephen Johnston is a Professor of Breast Cancer Medicine and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. He is currently a Clinical Director of the Breast, Lung and AOS Clinical Business Unit at The Royal Marsden. He has published over 250 breast cancer related articles in peer-reviewed journals, and is a regular invited lecturer at national and international meetings.

Dr. Sudeep Gupta is a Professor of Medical Oncology at Tata Memorial Hospital in Mumbai, India. Dr. Gupta obtained his MBBS degree from All India Institute of Medical Sciences (AIIMS) in New Delhi in 1992. He completed his Postgraduate (MD degree) in internal medicine in 1994.

Dr Tanya is Buckshee Rohatgi an internationally-trained consultant from the world’s leading IVF centres in England and Singapore. After passing out from the world-renowned Lady Harding Medical College in New Delhi, she worked for almost a decade in the best teaching hospitals in the UK. She was the only Indian to get a distinction award in her coveted MSc Programme in England and has more than 18 years of clinical experience in the field. She has helped set up the Oncofertility Programme for cancer survivors at Max Hospitals, India. The programme is now one of the best in the country. Her passion for research led her to start the Platelet Rich Plasma (PRP) Programme for patients with a persistent thin lining of the uterus.